Document is current
Any future updates will be listed below
-
Authors
Ianhez, Mayra https://orcid.org/0000-0003-3604-3128
Rodrigues, Ludmila Queiroz
Ianhez, Luiz Estevam
Ribeiro, Rafael Medeiros
Catharina, Guilherme Parise Santa
Kroumpouzos, George
Miot, Hélio Amante
- License Information
-
More Information
Article History
Received: 7 March 2025
Accepted: 14 May 2025
First Online: 23 July 2025
Declarations
:
: Dr. Mayra Ianhez: Advisory Board- Galderma, Sanofi, Pfizer, Novartis, Abbvie, Janssen, UCB-Biopharma, Boehringer-Ingelheim; Speaker—Galderma, Sanofi, Pfizer, Theraskin, Novartis, Abbvie, Janssen, Leopharma, FQM, Naos. Dr Ludmila Queiroz Rodrigues, Luiz Estevam Ianhez, Rafael Medeiros Ribeiro and George Krompouzos have no conflicts of interests. Dr Guilherme Parise Santa Catharina: Advisory Board: Fresenius Medical Care; Speaker: AstraZeneca; Medical Manager: Davitta Renal treatment. Dr. Hélio Miot: Advisory Board—Johnson & Johnson, L’Oréal, Theraskin, Beiersdorf, Sanofi e Pfizer; Clinical Reserarch—Abbvie, Galderma e Merz.
: The study protocol was approved by the Institutional Review Board (IRB) (#84038724.0.0000.0034).
: Patients provided written consent for the participation in the study and the publication of their data.
